RetinalGenix Technologies (RTGN) Total Non-Current Liabilities (2022 - 2026)

RetinalGenix Technologies (RTGN) reported Total Non-Current Liabilities of $1.7 million for Q1 2026, up 47.71% on a YoY basis from $1.2 million in Q1 2025, and down 5.53% sequentially from $1.8 million in Q4 2025.

RetinalGenix Technologies (RTGN) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

RetinalGenix Technologies (RTGN) has 5 years of Total Non-Current Liabilities data on file, last reported at $1.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities rose 47.71% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 47.71% YoY), and the FY2025 full-year result was $1.8 million, up 81.67% from the prior year.
  • Total Non-Current Liabilities retreated to $1.7 million in Q1 2026, from $1.8 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.8 million in Q4 2025 to a low of $459804.0 in Q2 2022.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities soared 110.05% in 2023 and retreated 14.76% in 2025, its largest moves.
  • Tracing RTGN's Total Non-Current Liabilities over 5 years: stood at $959815.0 in 2022, then slipped by 1.2% to $948279.0 in 2023, then climbed by 6.48% to $1.0 million in 2024, then jumped by 81.67% to $1.8 million in 2025, then fell by 5.53% to $1.7 million in 2026.
  • Business Quant data shows RTGN's Total Non-Current Liabilities at $1.7 million in Q1 2026, $1.8 million in Q4 2025, and $1.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 RetinalGenix Technologies 75.02 Mn 75.02 Mn - 1.73 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.73 Mn
Dec 31, 2025 1.83 Mn
Sep 30, 2025 1.64 Mn
Jun 30, 2025 1.44 Mn
Mar 31, 2025 1.17 Mn
Dec 31, 2024 1.01 Mn
Sep 30, 2024 1.47 Mn
Jun 30, 2024 1.35 Mn
Mar 31, 2024 1.38 Mn
Dec 31, 2023 948,279.00
Sep 30, 2023 1.08 Mn
Jun 30, 2023 965,824.00
Mar 31, 2023 1.31 Mn
Dec 31, 2022 959,815.00
Jun 30, 2022 459,804.00